pyrilamine has been researched along with framycetin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Ito, Y; Kashiwagi, S; Kimura, C; Oike, M | 1 |
| Higuchi, H; Nagai, S; Niki, T; Piao, H; Tsurumaki, T | 1 |
4 other study(ies) available for pyrilamine and framycetin
| Article | Year |
|---|---|
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship | 2008 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Effects of acute glucose overload on histamine H2 receptor-mediated Ca2+ mobilization in bovine cerebral endothelial cells.
Topics: Animals; Bradykinin; Brain; Bucladesine; Calcium; Cattle; Cells, Cultured; Cimetidine; Cyclic AMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Glucose; Histamine; Histamine Antagonists; Homeostasis; Microcirculation; Neomycin; Neurotransmitter Agents; Protein Kinase C; Pyrilamine; Ranitidine; Receptors, Histamine H2; Staurosporine | 1998 |
Potentiation by neuropeptide Y of histamine H1 receptor-mediated contraction in rat blood vessels.
Topics: Animals; Arteries; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Histamine; Histamine H1 Antagonists; In Vitro Techniques; Male; Neomycin; Neuropeptide Y; Phenylcarbamates; Pyrilamine; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Histamine H1; Receptors, Neuropeptide; RNA, Messenger; Type C Phospholipases; Vasoconstriction; Vasoconstrictor Agents; Veins | 2007 |